Research and Markets: Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/763e29/interventional_car) has announced the addition of GlobalData 's new report "Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" to their offering.

Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 provides key data, information and analysis on the global interventional cardiology devices market. The report provides market landscape, competitive landscape and market trends information on the interventional cardiology devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the market's competitive landscape and technology offerings.

The Global Interventional Cardiology Devices Market is Forecast to Reach $11.3 Billion by 2017

In 2010, the global market for interventional cardiology devices was valued at $10 billion and is forecast to reach $11.3 billion in 2017 at a Compound Annual Growth Rate (CAGR) of 2%. The market will be driven by growing prevalence of Coronary Heart Disease (CHD). Bioabsorbable stents, Percutaneous Transluminal Coronary Angioplasty (PTCA) coronary Drug Eluting Balloons (DEB) and Intravascular Ultrasound Systems (IVUS) are expected to drive the growth of the market through better efficacy and safety profiles, reduced procedure time and reduced procedure cost.

New techniques such as transradial intervention to minimize access site bleeding will contribute to an increase in Percutaneous Coronary Intervention (PCI) procedures. The coronary stents segment accounts for about 50% of the total revenue and will continue to influence the growth of the market for interventional cardiology devices. The market is forecast to experience modest growth over the next seven years, primarily due to price erosion in the coronary stents market.

Key Topics Covered:

• 1.1 List of Tables
• 1.2 List of Figures
• 2 Introduction
• 3 Disease Overview - Coronary Heart Disease (CHD)
• 4 Interventional Cardiology Devices - Overview
• 5 Interventional Cardiology Devices: Market Characterization
• 6 Interventional Cardiology Devices Market: Segment Analysis
• 7 Interventional Cardiology Devices Market, Revenue ($m), by Country, Revenue ($m), 2003-2017
• 8 Interventional Cardiology Devices Market: Strategic Competitive Assessment
• 9 Global Interventional Cardiology Devices: Strategic Pipeline Assessment
• 10 Interventional Cardiology Devices Market: M&A Landscape
• 11 Appendix

Companies Mentioned:

• Boston Scientific Corporation
• Abbott Laboratories
• Medtronic, Inc.
• Cordis Corporation
• Terumo Corporation

For more information visit http://www.researchandmarkets.com/research/763e29/interventional_car